We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
14.1
quarters
Top 10 Avg Time Held
19
quarters
Top 20 Avg Time Held
14.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1676
Microvision
MVIS
$36.7M
| $16.9K | ﹤0.01% |
1,758
+244
| +16% | +$2.79K |
2023 Q2
11 quarters
|
|
1677
Conduent
CNDT
$232M
| $16.7K | ﹤0.01% |
13,035
+1,689
| +15% | +$2.58K |
2023 Q2
11 quarters
|
|
1678
Xerox
XRX
$356M
| $13.6K | ﹤0.01% |
+10,578
| New | +$20.9K |
2026 Q1
0 quarters
|
|
1679
Heron Therapeutics
HRTX
$78.9M
| $11K | ﹤0.01% |
13,735
+1,842
| +15% | +$2.13K |
2025 Q2
3 quarters
|
|
1680
Quantum-Si Incorporated
QSI
$298M
| $10.7K | ﹤0.01% |
13,849
+2,025
| +17% | +$2.1K |
2025 Q2
3 quarters
|
|
1681
New Fortress Energy
NFE
$24.1M
| $9.22K | ﹤0.01% |
312
+40
| +15% | +$2.34K |
2025 Q2
3 quarters
|
|
1682
SkinHealth Systems
SKIN
$68.3M
| $9.18K | ﹤0.01% |
+10,317
| New | +$12.7K |
2026 Q1
0 quarters
|
|
1683
Humacyte
HUMA
$108M
| $8.19K | ﹤0.01% |
13,493
+1,943
| +17% | +$2.02K |
2025 Q4
1 quarter
|
|
1684
SelectQuote
SLQT
$63.3M
| $7.91K | ﹤0.01% |
12,568
+1,683
| +15% | +$1.77K |
2025 Q1
4 quarters
|
|
1685
Gossamer Bio
GOSS
$56.8M
| $5.65K | ﹤0.01% |
215
+29
| +16% | +$3.65K |
2025 Q2
3 quarters
|
|
|
FFAI
1686
Faraday Future Intelligent Electric
FFAI
$6.68M
| $3.7K | ﹤0.01% |
90
+16
| +22% | +$1.65K |
2025 Q4
1 quarter
|
|
1687
Agnico Eagle Mines
AEM
$95.3B
| – | – |
-4,776
| Closed | -$811K | – |
|
1688
Agilon Health
AGL
$1.44B
| – | – |
-971
| Closed | -$16.7K | – |
|
1689
Agilysys
AGYS
$2.98B
| – | – |
-2,123
| Closed | -$252K | – |
|
1690
Aimco
AIV
$257M
| – | – |
-10,471
| Closed | -$62.2K | – |
|
1691
Ambarella
AMBA
$2.86B
| – | – |
-3,248
| Closed | -$230K | – |
|
1692
Everforth Inc
EFOR
$1.53B
| – | – |
-5,266
| Closed | -$254K | – |
|
|
AVDL
1693
DELISTED
Avadel Pharmaceuticals
AVDL
| – | – |
-9,763
| Closed | -$210K | – |
|
1694
BlackLine
BL
$1.7B
| – | – |
-4,118
| Closed | -$228K | – |
|
1695
Bank of Montreal
BMO
$114B
| – | – |
-4,489
| Closed | -$584K | – |
|
1696
Brookfield
BN
$82.7B
| – | – |
-4,705
| Closed | -$216K | – |
|
1697
Braze
BRZE
$3.3B
| – | – |
-6,743
| Closed | -$231K | – |
|
1698
DELISTED
Cadence Bank
CADE
| – | – |
-22,663
| Closed | -$971K | – |
|
1699
CAE Inc
CAE
$7.63B
| – | – |
-12,370
| Closed | -$377K | – |
|
1700
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-1,532
| Closed | -$338K | – |
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.